As more evidenced by this settlement, the DOJ and SEC carry on to signal the threats connected with ill-described swimming pools of reimbursable distributor charges (e.g. “marketing and advertising” or “administration” expenditures), the usage of free samples, rebates, and other price tag concessions. The Alcon and Novartis AG DPAs certainl